Panel: No silver bullet for drug prices

Panel: No silver bullet for drug prices
As drug prices increase, states can pursue a number of policy maneuvers to help bend the cost curve, experts said at an Evidence-Based Health Policy Project briefing in Madison last week.
To access this content, you must purchase a Premium membership, or log in if you are a member.

STAY INFORMED ON THE STATE’S MOST PRESSING HEALTHCARE ISSUES AND INITIATIVES.

Subscribe here for a FREE 14 day trial of our daily news roundup.

You have Successfully Subscribed!

Pin It on Pinterest